New medicines for tropical diseases in pregnancy: catch-22
- PMID: 18563964
- PMCID: PMC2429948
- DOI: 10.1371/journal.pmed.0050133
New medicines for tropical diseases in pregnancy: catch-22
Abstract
Nicholas White and colleagues discuss why it is so important to conduct clinical trials of malaria treatments in pregnancy.
Conflict of interest statement
References
-
- World Health Organization. Maternal mortality in 2005. Estimates developed by WHO, UNICEF, UNFPA and the World Bank. 2007. Available: http://www.who.int/reproductive-health/publications/maternal_mortality_2.... Accessed 8 May 2008.
-
- Fisk NM, Atun R. Market failure and the poverty of new drugs in maternal health. PLoS Med. 2008;5:e22. doi: 10.1371/journal.pmed.0050022. - DOI - PMC - PubMed
-
- Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, et al. Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007;7:93–104. - PubMed
-
- Myint HY, Tipmanee P, Nosten F, Day NP, Pukrittayakamee S, et al. A systematic overview of published antimalarial drug trials. Trans R Soc Trop Med Hyg. 2004;98:73–81. - PubMed
-
- Tagbor HK, Chandramohan D, Greenwood B. The safety of amodiaquine use in pregnant women. Expert Opin Drug Saf. 2007;6:631–635. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
